Literature DB >> 31208777

Getting it right first time: The importance of a structured tissue sampling protocol for diagnosing fracture-related infections.

P Hellebrekers1, R J Rentenaar2, M A McNally3, F Hietbrink1, R M Houwert1, L P H Leenen1, G A M Govaert4.   

Abstract

INTRODUCTION: Fracture-related infection (FRI) is an important complication following surgical fracture management. Key to successful treatment is an accurate diagnosis. To this end, microbiological identification remains the gold standard. Although a structured approach towards sampling specimens for microbiology seems logical, there is no consensus on a culture protocol for FRI. The aim of this study is to evaluate the effect of a structured microbiology sampling protocol for fracture-related infections compared to ad-hoc culture sampling.
METHODS: We conducted a pre-/post-implementation cohort study that compared the effects of implementation of a structured FRI sampling protocol. The protocol included strict criteria for sampling and interpretation of tissue cultures for microbiology. All intraoperative samples from suspected or confirmed FRI were compared for culture results. Adherence to the protocol was described for the post-implementation cohort.
RESULTS: In total 101 patients were included, 49 pre-implementation and 52 post-implementation. From these patients 175 intraoperative culture sets were obtained, 96 and 79 pre- and post-implementation respectively. Cultures from the pre-implementation cohort showed significantly more antibiotic use during culture sampling (P =  0.002). The post-implementation cohort showed a tendency more positive culture sets (69% vs. 63%), with a significant difference in open wounds (86% vs. 67%, P =  0.034). In all post-implementation culture sets causative pathogens were cultured more than once per set, in contrast to pre-implementation. Despite stricter tissue sampling and culture interpretation criteria, the number of polymicrobial infections was similar in both cohorts, approximately 29% of all culture sets and 44% of all positive culture sets. Significantly more polymicrobial cultures were found in early infections in the post-implementation cohort (P =  0.048). This indicates a better yield in the new protocol.
CONCLUSION: A standardised protocol for intraoperative sampling for bacterial identification in FRI is superior than an ad-hoc approach. It has a positive effect on both surgeon and microbiologist by increasing awareness about the problem at hand. This resulted in more microbiologically confirmed infections and more certainty when identifying causative pathogens.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Cultures; Diagnosis; Fracture; Fracture-related infections; Infection; Microbiology; Osteomyelitis; Protocol; Tissue sampling; Trauma

Mesh:

Year:  2019        PMID: 31208777     DOI: 10.1016/j.injury.2019.05.014

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  12 in total

Review 1.  Current concepts in the prevention, diagnosis and treatment of fracture-related infection (FRI).

Authors:  Alexios Dimitrios Iliadis; Faiz Shivji; Ekansh Debuka; Alex Trompeter; Badri Narayan; Nima Heidari
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-03-29

2.  Tissue sampling is non-inferior in comparison to sonication in orthopedic revision surgery.

Authors:  Theresa Fritsche; Matthias Schnetz; Alexander Klug; Sebastian Fischer; Christian Ruckes; K P Hunfeld; Reinhard Hoffmann; Yves Gramlich
Journal:  Arch Orthop Trauma Surg       Date:  2022-05-25       Impact factor: 3.067

3.  Complete ejection of a ring sequestrum 8 years after external fixation of the tibia.

Authors:  Isabella Regina Timmer; Benjamin Lucas Emmink; Loek Petrus Hendrikus Leenen; Geertje Anna Maria Govaert
Journal:  BMJ Case Rep       Date:  2020-03-29

4.  Diagnosing Fracture-Related Infection: Current Concepts and Recommendations.

Authors:  Geertje A M Govaert; Richard Kuehl; Bridget L Atkins; Andrej Trampuz; Mario Morgenstern; William T Obremskey; Michael H J Verhofstad; Martin A McNally; Willem-Jan Metsemakers
Journal:  J Orthop Trauma       Date:  2020-01       Impact factor: 2.884

5.  Simultaneous debridement, Ilizarov reconstruction and free muscle flaps in the management of complex tibial infection.

Authors:  Max Mifsud; Jamie Y Ferguson; David A Stubbs; Alex J Ramsden; Martin A McNally
Journal:  J Bone Jt Infect       Date:  2020-12-22

Review 6.  Optimal microbiological sampling for the diagnosis of osteoarticular infection.

Authors:  Ricardo Sousa; André Carvalho; Ana Cláudia Santos; Miguel Araújo Abreu
Journal:  EFORT Open Rev       Date:  2021-06-28

7.  Diagnosing Fracture-Related Infections: Where Are We Now?

Authors:  Madeleine C Stevenson; Julia C Slater; H Claude Sagi; Federico Palacio Bedoya; Margaret V Powers-Fletcher
Journal:  J Clin Microbiol       Date:  2021-06-16       Impact factor: 11.677

8.  General treatment principles for fracture-related infection: recommendations from an international expert group.

Authors:  Willem-Jan Metsemakers; Mario Morgenstern; Eric Senneville; Olivier Borens; Geertje A M Govaert; Jolien Onsea; Melissa Depypere; R Geoff Richards; Andrej Trampuz; Michael H J Verhofstad; Stephen L Kates; Michael Raschke; Martin A McNally; William T Obremskey
Journal:  Arch Orthop Trauma Surg       Date:  2019-10-29       Impact factor: 3.067

9.  The accuracy of diagnostic Imaging techniques in patients with a suspected Fracture-related Infection (IFI) trial: study protocol for a prospective multicenter cohort study.

Authors:  Gam Govaert; Mgg Hobbelink; Ihf Reininga; P Bosch; T C Kwee; P A de Jong; P C Jutte; H C Vogely; Rajo Dierckx; Lph Leenen; Awjm Glaudemans; Ffa IJpma
Journal:  BMJ Open       Date:  2019-09-08       Impact factor: 2.692

10.  The Role of Negative-Pressure Wound Therapy in Patients with Fracture-Related Infection: A Systematic Review and Critical Appraisal.

Authors:  Susan Haidari; Frank F A IJpma; Willem-Jan Metsemakers; Wies Maarse; H Charles Vogely; Alex J Ramsden; Martin A McNally; Geertje A M Govaert
Journal:  Biomed Res Int       Date:  2021-10-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.